Last reviewed · How we verify
NCT04000750
Time-Restricted Eating and Muscle Hypertrophy
NA trial testing Time Restricted Eating in Muscle Hypertrophy in 20 participants. Completed in 5 February 2023.
15 July 2021
Quick facts
| Lead sponsor | California State University, Fullerton |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 20 |
| Start date | 24 June 2019 |
| Primary completion | 15 July 2021 |
| Estimated completion | 5 February 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Time Restricted Eating
- Normal Feeding
- Resistance Training
- Whey Protein
Conditions studied
- Muscle Hypertrophy — all drugs for Muscle Hypertrophy →
- Healthy and Well-Trained Men and Women — all drugs for Healthy and Well-Trained Men and Women →
Sponsor
California State University, Fullerton
Who can join
Adults 18 to 35, any sex, with Muscle Hypertrophy or Healthy and Well-Trained Men and Women. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose is to examine the effects of time-restricted eating (TRE; consuming all calories within an 8-hour period each day) vs. normal eating (CON; consuming same kcals and protein as TRE, but during a 10-13 hr eating window each day) during 8 weeks of resistance exercise on body composition and muscle mass (whole muscle and single fiber), muscular performance, anabolic protein signaling, single muscle fiber characteristics, and the gut microbiome in well-trained young men and women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04000750
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Time Restricted Eating
Trials testing the same drug.
- NCT07219706 — Dietary Fiber and Time Restricted Eating · NA · recruiting
- NCT07475377 — Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis · NA · not yet recruiting
- NCT07211217 — Time Restricted Eating (TRE) in Bipolar Disorder · NA · not yet recruiting
- NCT07259434 — Time Restricted Eating in Survivors Trial 2.0 · NA · not yet recruiting
- NCT06686667 — The Feasibility of Overnight Time Restricted Eating and Impact on Glucose Levels in Shift Workers · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04000750 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by California State University, Fullerton
- Last refreshed: 9 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04000750.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing